Filing Details
- Accession Number:
- 0001628280-21-010163
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-13 16:17:55
- Reporting Period:
- 2021-05-11
- Accepted Time:
- 2021-05-13 16:17:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1600620 | Aurinia Pharmaceuticals Inc. | AUPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1838521 | Hector R. Mackay-Dunn | #1203-4464 Markham Street Victoria A1 V8Z7X8 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-11 | 500 | $11.17 | 2,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-11 | 1,000 | $11.14 | 3,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 1,400 | $11.26 | 4,400 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 1,600 | $11.28 | 6,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |